Traceable reference standards is becoming an indispensable tool for pharmaceutical companies to identify therapeutic targets and pharmacodynamic biomarkers

Active Cooperative Agreement Awarded Last action

Award ID
70NANB24H198
Recipient
Awarding agency
Obligated
$400,000

Award facts

Completion date 83% complete
Originally
Place of performance
San Antonio, TX 78229, USA

Award details come from USAspending.gov.

Description

Expected outcomes
The achievements realized in its sbir phase i project will carry over to this phase II project where synamap will expand into developing a computational quantitative normalization approach from calibration standards.
Intended beneficiaries
Recipient's intended beneficiaries include biotech and pharmaceutical companies interested in therapeutic target and biomarker discovery.
Subrecipient activities
The recipient does not intend to make subawards for this phase II project.

Transactions

Action Obligated Date
Amendment $0
Original award $400,000

Quick answers

Who received award 70NANB24H198?

70NANB24H198 was awarded to Sygnamap Inc. by National Institute of Standards and Technology (Department of Commerce) on October 1, 2024.

How much is award 70NANB24H198 worth?

$400,000 has been obligated on 70NANB24H198.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award